Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00225212
What this trial is testing

Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaDiffuse Large Cell LymphomaMantle Cell Lymphoma+3 more
Stanford University 35
Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Not applicableEnded earlyNCT02360111
What this trial is testing

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 3
Large-scale testing (Phase 3)Ended earlyNCT04326764
What this trial is testing

Panobinostat Maintenance After HSCT fo High-risk AML and MDS

Who this might be right for
Acute Myeloid Leukaemia (AML)Myelodysplastic Syndromes (MDS)
Goethe University 52
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00146614
What this trial is testing

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseHematologic Malignancies
Dana-Farber Cancer Institute 105
Not applicableStudy completedNCT06000306
What this trial is testing

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Who this might be right for
Measurable Residual Disease
Zhejiang University 192
Testing effectiveness (Phase 2)Study completedNCT00504634
What this trial is testing

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT05149365
What this trial is testing

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Who this might be right for
Acute-graft-versus-host DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 190
Very early researchLooking for participantsNCT06735690
What this trial is testing

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
City of Hope Medical Center 15
Not applicableStudy completedNCT07150468
What this trial is testing

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Who this might be right for
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma
Asan Medical Center 146
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Not applicableStudy completedNCT00789516
What this trial is testing

The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation

Who this might be right for
Thalassemia
Mahidol University 60
Not applicableStudy completedNCT05515497
What this trial is testing

BMT4me: Post-HSCT Medication Adherence mHealth App

Who this might be right for
Stem Cell TransplantAdherence, MedicationDigital Health
Micah Skeens 50
Not applicableUnknownNCT00563108
What this trial is testing

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Hospital Authority, Hong Kong 60
Testing effectiveness (Phase 2)Study completedNCT01283776
What this trial is testing

Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation

Who this might be right for
Multiple MyelomaNon-Hodgkin-LymphomaHodgkin's Disease
University of Cologne 11
Testing effectiveness (Phase 2)Study completedNCT03339297
What this trial is testing

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Who this might be right for
Graft-versus-host DiseaseAcute-graft-versus-host Disease
Jazz Pharmaceuticals 152
Post-approval studies (Phase 4)Study completedNCT00616135
What this trial is testing

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastMammaplasty+1 more
Cytori Therapeutics 71
Next Page
35